Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters











Database
Publication year range
1.
Fortschr Neurol Psychiatr ; 75(3): 168-71, 2007 Mar.
Article in German | MEDLINE | ID: mdl-17230307

ABSTRACT

The purpose of this prospective, randomised and controlled study was to evaluate which kind of operative technique for treatment of cubital tunnel syndrome is favourable: subcutaneous anterior transposition or nerve decompression without transposition. This study included 66 patients suffering from pain and/either neurological deficits with clinically and electrographically proven cubital tunnel syndrome. 32 patients underwent nerve decompression without transposition, whereas 34 underwent subcutaneous transposition of the nerve. Follow-up examinations evaluating pain, motor and sensory deficits as well as motor nerve conduction velocities were performed three, nine and 24 months postoperatively. Irrespectively of operative procedures (simple decompression vs. subcutaneous anterior transposition) there were no significant differences between the outcomes of the two groups at either postoperative follow-up examination (p > 0.05).


Subject(s)
Cubital Tunnel Syndrome/surgery , Decompression, Surgical , Neurosurgical Procedures , Ulnar Nerve/surgery , Aged , Cubital Tunnel Syndrome/complications , Cubital Tunnel Syndrome/diagnosis , Electrodiagnosis , Female , Follow-Up Studies , Humans , Male , Middle Aged , Motor Neurons/physiology , Neural Conduction/physiology , Pain/diagnosis , Pain/etiology , Pain Measurement , Treatment Outcome
2.
Nervenarzt ; 76(12): 1515-9, 2005 Dec.
Article in German | MEDLINE | ID: mdl-15841392

ABSTRACT

We report the case of a 64-year-old male suffering from long-term claudicatio spinalis who underwent surgery in an orthopedic outpatient ward for posterior lumbar interbody fusion and bony decompression due to spinal stenosis. Postoperatively, the clinical symptoms, consisting of difficulties with walking and stocking-like dysesthesia of both lower extremities, did not improve. Due to persistent complaints, spinal MRI was performed which revealed myelomalacia and moreover was indicative of dural arteriovenous (AV) malformation at the L2-3 spinal level, which was verified as a type Ia AV fistula (according to Spetzler) by digital subtraction angiography (DSA). After microsurgical treatment of the AV fistula, clinical symptoms improved and control DSA could demonstrate complete disconnection of the fistula without any signs of recanalization. This case demonstrates that neurological deficits of patients suffering from degenerative spinal disorders can generally be considered as caused by more common spinal disease such as lumbar stenosis. Since vascular malformations may also cause neurological deficits and even mimic symptoms of spinal stenosis, it is important to consider these entities in diagnostic evaluation.


Subject(s)
Arteriovenous Malformations/diagnosis , Arteriovenous Malformations/surgery , Lumbar Vertebrae/surgery , Spinal Cord/blood supply , Spinal Cord/surgery , Spinal Stenosis/diagnosis , Spinal Stenosis/surgery , Arteriovenous Malformations/complications , Diagnosis, Differential , Humans , Male , Middle Aged , Spinal Stenosis/complications , Syndrome , Treatment Outcome , Vertebral Artery/abnormalities , Vertebral Artery/surgery
3.
J Neural Transm (Vienna) ; 109(5-6): 691-709, 2002 May.
Article in English | MEDLINE | ID: mdl-12111461

ABSTRACT

To test substances which might have protective effects on the dopaminergic system it is necessary to use models with a pathological symptomatology of the early beginning, i.e. models in which the chance exists to arrest the otherwise progressive pathological processes (see Heim et al., 2001). 6-hydroxydopamine (6-OHDA) injected unilaterally into the ventrolateral striatum of rats (6 microg dissolved in 2 microl 0.2% ascorbic acid) leads to specific stereotyped movements after subcutaneous injection of apomorphine both 3 and 13 weeks after surgery. Ten weeks after surgery decreased spontaneous motor activity could be observed. Twelve weeks after 6-hydroxydopamine injection, the animals had difficulties in performing a spatial navigation task when the submerged escape platform was moved to another position. The switching of motor programs was less pronounced. The application of tyrosine-hydroxylase-staining showed a loss of ipsilateral neurones of the substantia nigra compacta as well as of dendrites in the pars reticulata, neurones in the ventral tegmental area and in the retrorubral area ipsilaterally as well as a loss of dopaminergic fibres both ipsilaterally and contralaterally in the striatum which should belong to the contralateral acting substantia nigra afferents. The loss of the neurones and the afferents was induced by the retrograde denervation following the 6-OHDA injection within the ventrolateral striatum. The question arises whether the model used here with the partially loss of dopaminergic neurons and fibres reflects some of pathological symptoms of Parkinson's disease in the early states.


Subject(s)
Dopamine/metabolism , Neurons/metabolism , Parkinson Disease/metabolism , Red Nucleus/metabolism , Substantia Nigra/metabolism , Substantia Nigra/pathology , Tegmentum Mesencephali/metabolism , Animals , Antiparkinson Agents/pharmacology , Apomorphine/pharmacology , Behavior, Animal/drug effects , Dopamine Agonists/pharmacology , Male , Maze Learning/drug effects , Motor Activity/drug effects , Neurons/pathology , Oxidopamine , Parkinson Disease/pathology , Parkinson Disease/psychology , Parkinson Disease, Secondary/chemically induced , Rats , Rats, Wistar , Red Nucleus/pathology , Swimming , Tegmentum Mesencephali/pathology
4.
Ann Rheum Dis ; 57(7): 414-21, 1998 Jul.
Article in English | MEDLINE | ID: mdl-9797568

ABSTRACT

OBJECTIVE: Methotrexate (MTX) has become the disease modifying drug of choice for the treatment of rheumatoid arthritis (RA). Direct effects of MTX on articular cartilage in vivo and in vitro were studied to determine possible adverse effects of the drug. METHODS: For in vitro experiments, adult bovine articular cartilage explants were cultured in the presence of MTX (0 to 100 microM), and effects on DNA and matrix metabolism were studied. For in vivo studies, 48 adult female rabbits were treated with MTX (30 mg/kg/week intramuscularly) or placebo, respectively, for up to 12 weeks, and effects on the cartilage of the femoral condyles were assessed. RESULTS: In vitro, MTX dose dependently increased the uptake of [3H]-thymidine, and decreased incorporation of [3H]-d-uridine into chondrocytes with a half maximal effect at 0.03 microM, suggesting inhibition of thymidylate-synthetase activity by the drug. MTX also dose dependently reduced the proportion of chondrocytes in S-phase, as determined by flow cytometry. MTX did not affect LDH release from chondrocytes or the proportion of viable cells, nor did it change the rate of protein synthesis, proteoglycan synthesis, proteoglycan breakdown, or the hydrodynamic size of newly synthesised proteoglycans. In vivo, MTX did not appreciably affect proteoglycan synthesis of the chondrocytes, proteoglycan content of the cartilage matrix, density of the chondrocyte population, or histological integrity of the cartilage. CONCLUSIONS: The data suggest the absence of major adverse effects by MTX on articular cartilage proteoglycan metabolism. Chondrocyte DNA metabolism seems to be changed by MTX only in concentrations and exposition periods clearly exceeding those found in synovial fluid of RA patients receiving the commonly prescribed doses of the drug.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Cartilage, Articular/drug effects , Methotrexate/pharmacology , Animals , Anti-Inflammatory Agents/pharmacokinetics , Cartilage, Articular/metabolism , Cattle , Cell Division/drug effects , Culture Techniques , DNA/metabolism , Dose-Response Relationship, Drug , Female , Hindlimb , Injections, Intramuscular , Methotrexate/pharmacokinetics , Proteoglycans/analysis , Rabbits , Steroids , Synovial Fluid/chemistry , Synovial Fluid/metabolism
5.
Nurs Manage ; 28(11): 48B-48E, 1997 Nov.
Article in English | MEDLINE | ID: mdl-9385158

ABSTRACT

The nursing care system in a university hospital was modified to accommodate children on an organ transplant unit. System components for ensuring high-quality care for patients of all ages are identified and described. Primary nursing, a Pediatric Nursing Practice Council, Child Family Life and the support of the health care team are incorporated to successfully care for adults and children on this specialty unit.


Subject(s)
Family , Hospital Units/organization & administration , Organ Transplantation/nursing , Pediatric Nursing/organization & administration , Adult , Child , Humans , Quality Assurance, Health Care
6.
Z Orthop Ihre Grenzgeb ; 134(4): 381-5, 1996.
Article in German | MEDLINE | ID: mdl-8928570

ABSTRACT

OBJECTIVE: To determine whether the activity of cartilage-degrading enzymes in the synovial fluid (SF) of patients with rheumatoid arthritis and other joint diseases is correlated with the concentration of cytokines in the SF. METHODS: Cytokines and cartilage-degrading enzymes were determined in the SF of 97 patients with various disorders involving the knee joints (rheumatoid arthritis (RA) n 44; osteoarthritis (OA) n 35; meniscal trauma (Men) n 10; reactive arthritides (ReA) n 8). In these samples we measured the concentrations of interleukin-1 alpha and beta, IL-1-receptor antagonist (IL-1ra), IL-6, IL-8, tumor necrosis factor alpha (TNF alpha; all by ELISA), collagenase-activity and caseinase-activity (by substrate assays). RESULTS: With the exception of IL-1 alpha and IL-6, cytokine-concentrations were significantly higher in RA than in OA SF-samples (p < 0.05; ANOVA on ranks). IL-1ra, IL-6, and IL-1 beta were correlated best with the collagenase-activity in the SF (r = 0.63; 0.57; 0.55; Spearman's rank correlation), while IL-1 beta (r = 0.53) and IL-1ra (r = 0.52) were best correlated with the caseinase-activity in the samples. The SF-concentration of IL-1ra was well correlated with the levels of IL-6, IL-1 beta, II-8, and TNF alpha (r from 0.73 to 0.66; all p < 0.005), but not with IL1 alpha. The molar ratio of IL-1 to IL-1ra in the SF was neither correlated with the activity of collagenase nor caseinase. IL-1 beta and IL-1ra in the SF were positively correlated with the erythrocyte sedimentation rate (ESR). CONCLUSIONS: The determination of IL-1 beta and IL-1ra in the SF of patients with joint disorders as examined in this study seems to allow to a certain extent a prediction of the collagenase- and caseinase-activity contained in the diseased joint. We would favor.


Subject(s)
Arthritis/metabolism , Cytokines/analysis , Synovial Fluid/chemistry , Arthritis, Rheumatoid/metabolism , Collagenases/analysis , Humans , Interleukins/analysis , Metalloendopeptidases/analysis , Osteoarthritis/metabolism , Predictive Value of Tests , Prohibitins , Synovial Fluid/enzymology , Tumor Necrosis Factor-alpha/analysis
7.
Arch Orthop Trauma Surg ; 114(1): 43-8, 1994.
Article in English | MEDLINE | ID: mdl-7696049

ABSTRACT

Interleukin 1 (IL-1) is a cytokine which induces cartilage proteoglycan (PG) depletion by inhibiting PG synthesis and increasing PG breakdown. Insulin-like growth factor I (IGF-I), in contrast, is known to promote matrix formation. We examined the effects of both mediators in a bovine tissue culture model. IL-1 dose-dependently inhibited PG formation of articular cartilage [half-maximal effect (EC50) at 4 ng/ml], while PG synthesis was increased by IGF-I (EC50 = 15 ng/ml). After inhibition of PG formation with IL-1 for 2 days and subsequent removal of free IL-1, addition of IGF-I dose-dependently accelerated restoration of the original rate of synthesis with a half-maximal effect at 20 ng/ml and a maximal effect at 50 ng/ml. The IGF-I concentration required to elicit a half-maximal effect on cartilage PG synthesis remained constant in the absence or presence of IL-1. We therefore conclude that inhibition of cartilage PG synthesis by IL-1 is not effected by damage to the IGF receptor. Synovial fluid (SF) of 40 patients with rheumatoid arthritis (RA) was found to contain 64 +/- 6 ng IGF-I/ml (mean +/- SEM). The reported effects of IGF-I in vitro therefore occurred at concentrations comparable to those present in joints in vivo. IL-1 beta was detectable (> 0.5 pg/ml) in 38 of 40 RA-SF samples (mean 28 +/- 6 pg/ml).(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Cartilage, Articular/metabolism , Insulin-Like Growth Factor I/physiology , Interleukin-1/physiology , Proteoglycans/biosynthesis , Arthritis, Rheumatoid/metabolism , Cartilage, Articular/drug effects , Culture Techniques , Dose-Response Relationship, Drug , Humans , Insulin-Like Growth Factor I/analysis , Insulin-Like Growth Factor I/pharmacology , Interleukin-1/analysis , Interleukin-1/pharmacology , Synovial Fluid/chemistry , Synovial Fluid/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL